ArticleOncoTargets and therapy2018

Successful alternative treatment for relapsed adult acute lymphoblastic leukemia with dendritic cells-cytokine-induced killer cells combined with a rituximab-based regimen.

XiaoFang Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.